News and Publications

  • Update on screening cut-offs for Gaucher and Pompe diseases

    April 28, 2025

    Effective 1 May 2025, the cut-off values for enzymatic testing for Gaucher and Pompe diseases have changed.The new Glucocerebrosidase (Gaucher) cut-off is changed to >1.2 µmol/L/h (old… Read more

  • Award for Outstanding Achievements on Rare Diseases

    ARCHIMEDlife News , Diagnostics April 17, 2025
    We are very happy to share that our CEO, Dr. David C. Kasper, has been selected as the winner of the Award for Outstanding Achievements in… Read more
  • WORLDSymposium 2025 Poster Presentations – Updates on important diagnostic services

    ARCHIMEDlife News , Diagnostics February 21, 2025
    The WORLDSymposium for Lysosomal Storage Disorders convened in San Diego, CA, USA earlier this month. This important meeting brings together industry, physicians, advocate groups, and… Read more
  • Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy

    Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder characterized by progressive neurodegeneration due to a deficiency in the enzyme arylsulfatase-A (ARSA). This deficiency leads to… Read more

  • MedLab Dubai

    MedLab Dubai. New directors appointed.

    ARCHIMEDlife News October 23, 2023
    New directors appointed: @Gröning, MD, as Medical Director, Dr. med. Thomas Winkler , MD and David C. Kasper (also as Manager). Our mission together with our highly experienced local… Read more
  • Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease

    Publications , Diagnostics June 1, 2023

    Acid sphingomyelinase deficiency (ASMD), commonly called Niemann-Pick A/B disease, is an autosomal recessively inherited lysosomal storage disorder resulting from a deficiency in acid sphingomyelinase (ASM)… Read more